194 related articles for article (PubMed ID: 24165382)
1. Efficacy of a travelers' diarrhea vaccine system in travelers to India.
Steffen R; Cramer JP; Burchard G; Jelinek T; Schwarz U; Ramdas P; Chatterjee S; Jiang ZD; DuPont HL; Dewasthaly S; Westritschnig K; Behrens RH
J Travel Med; 2013; 20(6):374-9. PubMed ID: 24165382
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
[TBL] [Abstract][Full Text] [Related]
5. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
6. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
Frech SA; Dupont HL; Bourgeois AL; McKenzie R; Belkind-Gerson J; Figueroa JF; Okhuysen PC; Guerrero NH; Martinez-Sandoval FG; Meléndez-Romero JH; Jiang ZD; Asturias EJ; Halpern J; Torres OR; Hoffman AS; Villar CP; Kassem RN; Flyer DC; Andersen BH; Kazempour K; Breisch SA; Glenn GM
Lancet; 2008 Jun; 371(9629):2019-25. PubMed ID: 18554712
[TBL] [Abstract][Full Text] [Related]
7. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.
Meraz IM; Jiang ZD; Ericsson CD; Bourgeois AL; Steffen R; Taylor DN; Hernandez N; DuPont HL
J Travel Med; 2008; 15(6):412-8. PubMed ID: 19090795
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
Jelinek T; Kollaritsch H
Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco.
Sack RB; Froehlich JL; Zulich AW; Hidi DS; Kapikian AZ; Orskov F; Orskov I; Greenberg HB
Gastroenterology; 1979 Jun; 76(6):1368-73. PubMed ID: 374178
[TBL] [Abstract][Full Text] [Related]
10. Travelers' diarrhea.
Hill DR; Beeching NJ
Curr Opin Infect Dis; 2010 Oct; 23(5):481-7. PubMed ID: 20683261
[TBL] [Abstract][Full Text] [Related]
11. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
[TBL] [Abstract][Full Text] [Related]
12. Travelers' diarrhea: microbiologic bases for prevention and treatment.
Sack RB
Rev Infect Dis; 1990; 12 Suppl 1():S59-63. PubMed ID: 2406857
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report).
Wiedermann G; Kollaritsch H; Kundi M; Svennerholm AM; Bjare U
J Travel Med; 2000 Jan; 7(1):27-9. PubMed ID: 10689236
[TBL] [Abstract][Full Text] [Related]
14. Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.
Kharat VB; Ahmed M; Jiang ZD; Riddle MS; DuPont HL
Am J Trop Med Hyg; 2017 Jan; 96(1):83-87. PubMed ID: 28077742
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
16. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.
Lundkvist J; Steffen R; Jönsson B
J Travel Med; 2009; 16(1):28-34. PubMed ID: 19192125
[TBL] [Abstract][Full Text] [Related]
17. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
Sack DA; Shimko J; Torres O; Bourgeois AL; Francia DS; Gustafsson B; Kärnell A; Nyquist I; Svennerholm AM
Vaccine; 2007 May; 25(22):4392-400. PubMed ID: 17448578
[TBL] [Abstract][Full Text] [Related]
18. Vaccines against enterotoxigenic Escherichia coli.
Svennerholm AM; Tobias J
Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
[TBL] [Abstract][Full Text] [Related]
19. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
Flores J; DuPont HL; Jiang ZD; Belkind-Gerson J; Mohamed JA; Carlin LG; Padda RS; Paredes M; Martinez-Sandoval JF; Villa NA; Okhuysen PC
J Travel Med; 2008; 15(3):156-61. PubMed ID: 18494692
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
